Aquilo Capital Management

Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ARWR, BPMC, KYMR, ARVN, SLN, and represent 69.80% of Aquilo Capital Management's stock portfolio.
  • Added to shares of these 4 stocks: XBI (+$18M), RPTX, KYMR, STRO.
  • Started 3 new stock positions in XBI, RPTX, STRO.
  • Reduced shares in these 9 stocks: BPMC (-$12M), SLN, CCCC, MRUS, GMAB, ARGX, OLMA, PIRS, RGNX.
  • Sold out of its positions in ARGX, CCCC, GMAB, OLMA, PIRS.
  • Aquilo Capital Management was a net seller of stock by $-1.6M.
  • Aquilo Capital Management has $161M in assets under management (AUM), dropping by 45.40%.
  • Central Index Key (CIK): 0001591986

Tip: Access up to 7 years of quarterly data

Positions held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Aquilo Capital Management

Aquilo Capital Management holds 10 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arrowhead Pharmaceuticals (ARWR) 17.3 $28M 909k 30.60
 View chart
Blueprint Medicines (BPMC) 14.6 $24M -32% 255k 92.24
 View chart
Kymera Therapeutics (KYMR) 14.0 $22M +12% 881k 25.46
 View chart
Arvinas Ord (ARVN) 12.5 $20M 489k 41.16
 View chart
Silence Therapeutics Ads (SLN) 11.3 $18M -20% 1.0M 17.37
 View chart
S&p Biotech Etf Tr Unit Put Option (XBI) 11.1 $18M NEW 200k 89.29
 View chart
Regenxbio Inc equity us cm (RGNX) 9.0 $14M -5% 802k 17.95
 View chart
Merus N V (MRUS) 6.1 $9.8M -17% 355k 27.50
 View chart
Repare Therapeutics Ord (RPTX) 2.9 $4.6M NEW 633k 7.30
 View chart
Sutro Biopharma (STRO) 1.1 $1.8M NEW 421k 4.29
 View chart

Past Filings by Aquilo Capital Management

SEC 13F filings are viewable for Aquilo Capital Management going back to 2018

View all past filings